GC101 Clinical Trials
2 recruitingGenetic
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
Spinal Muscular Atrophy
GeneCradle Inc18 enrolled4 locationsNCT05824169
Recruiting
Phase 1Phase 2
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
Spinal Muscular Atrophy Type 3
GeneCradle Inc21 enrolled1 locationNCT06421831